Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Emerging Tests-dtet
Dissecting the Data Behind Healthcare AI
How do the underlying datasets affect artificial intelligence tools’ performance in the lab—and beyond?
Has Your AI Been Validated?
Many artificial intelligence-based medical devices have not undergone clinical validation—but what does this mean for the lab?
SIDs Results From Genetic Heart Disease Less Than Previously Thought
From - Diagnostic Testing & Emerging Technologies
The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause…
Researchers Develop First Multiplex Test for Tick-Borne Disease Detection
From - Diagnostic Testing & Emerging Technologies
Researchers have developed the first multiplex array for diagnosis of tickborne diseases, according to a study published online…
Evidence for Liquid Biopsy Lacking, Expert Panel Finds
From - Diagnostic Testing & Emerging Technologies
There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published…
Dermatology Conference Highlights Gene Expression Tests for Skin Cancer
From - Diagnostic Testing & Emerging Technologies
Several companies presented findings at the American Academy of Dermatology's annual meeting (Feb. 16-18, San Diego) indicating that…
Genotype-Matched Diets Don’t Aid Weight Loss
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Set Record in 2017 for Targeted Therapy Approvals
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…
FDA Approves First Objective Blood Test for Concussion Evaluation
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first blood test to evaluate concussions in adults…
Study Shows Progress Towards a Blood-Based, Multi-Cancer Screen
From - Diagnostic Testing & Emerging Technologies
A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published…
Penicillin Skin Testing Can Delabel Misidentified Allergic Patients
From - Diagnostic Testing & Emerging Technologies
In an era of growing concerns over antibiotic stewardship, there is renewed interest in delabeling misidentified penicillin allergies as part of quality improvement efforts…